AFL

Executive Summary

A 44-Year Dividend Aristocrat Priced for Modest Total Return

Aflac (AFL) trades at $114.85, near the top of its 52-week range ($97-$120) after a steady year. Q1 2026 showed net EPS of $1.98 and adjusted EPS of $1.75 (+5.4%), but adjusted EPS missed the $1.79 consensus, while reported revenue of $4.3B (+27.9%) beat. The bull case is durability, not growth: 44 consecutive years of dividend increases (a Dividend Aristocrat), a conservative ~33% payout ratio, a ~2.1% yield, and a 5-year dividend CAGR of ~16.9%. Aflac returned $1.3B in Q1 ($1.0B buybacks + $315M dividends) on top of $4.8B in 2025. The drag is structural: Japan net earned premiums fell 3.8% in yen on reinsurance and paid-up policies, and a weak yen (¥156.87 avg) clips earnings. With shares near highs and Street consensus Neutral (avg target ~$113-$116), upside is limited; the appeal is a safe, fast-growing dividend backed by a fortress balance sheet (BVPS $58.69).

Fundamentals

Q1 2026 Snapshot — Adjusted EPS +5.4% on buyback-driven share count, but Japan premiums and FX remain a top-line headwind. Capital return stays the core attraction.

Revenue (Q1'26)

$4.3B

+27.9% YoY · beat consensus

Adjusted EPS

$1.75

+5.4% YoY · missed $1.79 est

Net EPS (Diluted)

$1.98

vs $0.05 a year ago

Japan Pretax Adj.

$759M

¥119.1B · margins improving

U.S. Pretax Adj.

$363M

Net earned premium +3.5%

Capital Returned (Q1)

$1.3B

$1.0B buyback + $315M dividend

Book Value / Share

$58.69

Equity $30.0B · up from $48.55

Forward P/E

15.8x

FY26e EPS ~$7.28

Quarterly Adjusted Revenue Trend

$4.5B

Q2'25

$4.7B

Q3'25

$4.2B

Q4'25

$4.3B

Q1'26

Dividend Engine

A Fortress Balance Sheet Funding a Decades-Long Dividend Compounder

44 yrs

Consecutive Dividend Hikes

Dividend Aristocrat · raised Q1'26 +5.2%

~33%

Dividend Payout Ratio

Ample coverage · room to keep raising

+16.9%

5-Year Dividend CAGR

Accelerating vs 11.9% 10-yr CAGR

Aug 2025

Q2 2025: Adj EPS $1.78 (+4.1% beat)

Beat Zacks consensus by 4.1% on strong Miraito cancer-product sales in Japan and solid U.S. persistency, though adj EPS fell 2.7% YoY.

Nov 2025

Q3 2025: Adj EPS $2.49 (+38.3% beat)

Large beat on strong investment income and U.S. group life/disability sales; adj EPS up 15.3% YoY. Full-year 2025: $3.5B buyback, $4.8B total returned.

Apr 30, 2026

Q1 2026: Adj EPS $1.75, missed $1.79

Revenue $4.3B (+27.9%) beat; adj EPS +5.4% but below consensus. Japan NEP -3.8% in yen; dividend raised 5.2% to $0.61/qtr. $1.3B returned.

May 26, 2026

Piper Sandler Raises Target to $130

John Barnidge lifted PT to $130 from $125 (Overweight), favoring insurance carriers over brokers, even as the broader Street stays Neutral.

May 2026

Japan / FX Overhang Persists

Bear thesis centers on declining Japan premiums (reinsurance, paid-up policies) and a weak yen (~¥157); bull thesis is durable buybacks and dividend safety.

Earnings & Signals

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus$7.28 (FY2026e)

FY+2 EPS Consensus$7.65 (FY2027e)

PEG Ration/m (flat EPS)

Forward P/E15.8x

EPS Revisions (90d)↑4 ↓8 (Net downward — estimates trimmed modestly post-Q1'26 miss on Japan premium softness and FX, partially offset by buyback accretion.)

Guidance AccuracyReliable — Aflac historically guides conservatively on premiums and capital return; FX is the main swing factor it cannot control.

Earnings Surprise Track Record

Q2'25 Est: $1.71 Act: $1.78 +4.1%

Q3'25 Est: $1.80 Act: $2.49 +38.3%

Q4'25 Est: $1.66 Act: $1.62 -2.4%

Q1'26 Est: $1.79 Act: $1.75 -2.2%

Beat RateBeat on adjusted EPS in 2 of last 4 quarters

Insider Activity (90 Days)

Net Buying/SellingNet selling (modest)

Sell/Buy RatioSell-tilted (routine 10b5-1)

Neutral

Trailing-90-day insider activity is modestly sell-tilted via routine 10b5-1 plans and option-related dispositions — typical for a mature, dividend-focused large cap. No signal of distress or unusual conviction either way.

Peer Comparison

Relative Valuation vs. Competitors

Company	P/E (fwd)	Div Yield	Payout Ratio	P/B
Aflac	15.8x	2.1%	33%	1.96x
MetLife	9.0x	2.8%	45%	1.8x
Prudential	8.2x	4.8%	53%	1.3x
Unum Group	7.0x	2.2%	20%	1.3x

AFL trades at a clear premium to U.S. life-insurance peers on forward P/E (~15.8x vs 7-9x) and price-to-book (~2.0x), reflecting its high-margin supplemental model, strong ROE, and Dividend Aristocrat status. Its ~2.1% yield is below MET (2.8%) and well below PRU (4.8%), but its ~33% payout leaves the most room to keep raising. The premium is the price of dividend durability, not growth — AFL's earnings are flat-to-down on Japan/FX headwinds.

Valuation

Price Targets & Scenarios

Scenario	Price Target	Assumptions	Probability
Bull Case	$140	Japan premium decline stabilizes as Miraito and Tsumitasu gain traction; yen strengthens toward ¥140, lifting translated earnings; U.S. group momentum compounds; aggressive buybacks shrink the share count and the multiple re-rates toward 18x.	25%
Base Case	$118	Japan premiums keep gently declining while margins hold; FX stays a modest drag near ¥155; EPS roughly flat at ~$7.25-7.40; buybacks and a ~5% dividend hike drive total return; multiple holds near 16x.	50%
Bear Case	$95	Sustained yen weakness (¥165+) and accelerating Japan premium runoff pressure earnings; U.S. claims/expense ratios deteriorate; investment income normalizes lower, and the multiple de-rates below 14x on a slow-growth supplemental insurer.	25%

Probability-Weighted Target: $118 (+3% from current price)

$118

Weighted

Bull $14025%

Base $11850%

Bear $9525%

Analyst Consensus

Piper Sandler

$130

Overweight / Raised

Street Average

$116

Neutral / Hold

Street Low

$100

Underweight / Cautious

Street High

$130

Buy / Bullish

Neutral consensus across ~13-24 analysts. Average 12-month target ~$113-$116 implies roughly flat-to-+3% upside from $114.85, with a high of $130 and a low of $100. The Street views AFL as a fairly valued income holding rather than a growth idea.

Technical

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High

$119.81

All-Time-High Close

$118.06

Current Price

$114.85

50-Day MA

$112.20

200-Day MA

$108.40

Support

$105.00

52-Week Low

$97.01

OptOptions & Sentiment

Implied Volatility (30D): ~22% (low)
IV Percentile: ~30% (subdued)
Put/Call Ratio (OI): 0.71 · call-tilted
Short Interest: ~1.5% float (low)
Days to Cover: ~2.5 days
Max Pain (near-term): ~$115
30D IV Skew: Balanced (low-vol income name)
Options Volume Trend: Muted · low-beta insurer

Risk & Ownership

Risk Assessment & Insider Signals

!Risk Factors

Japan premium runoff: Japan net earned premiums fell 3.8% in yen in Q1'26 (underlying -1.3%) on external reinsurance for WAYS/Tsumitasu and limited-pay policies reaching paid-up status. With Japan ~70% of earnings, persistent top-line erosion caps EPS growth.
Yen / FX translation drag: The average yen rate of ¥156.87 was 2.8% weaker YoY, a -$0.02 EPS hit in Q1. A sustained weak yen continues to compress dollar-reported Japan earnings and book value.
Valuation full vs. flat earnings: At ~15.8x forward and ~2.0x book — a premium to life peers at 7-9x — AFL offers little multiple support while FY26 consensus EPS (~$7.28) is roughly flat-to-down. Shares sit near 52-week highs.
Investment-income normalization: Recent quarters leaned on strong variable and floating-rate investment income; lower rates, reduced call income, or credit losses in the alternatives/CLO book would pressure a key earnings tailwind.
U.S. claims / persistency softening: U.S. growth depends on group voluntary and persistency; a weaker labor market or rising benefit ratios in supplemental health would slow the one segment still growing premiums.
Buyback dependence for EPS growth: Much of adjusted-EPS growth is share-count reduction rather than organic earnings; if capital is redirected or valuation rises, the EPS-accretion engine slows.

OOwnership & Insider Signals

Institutional ownership ~70%: Roughly 70% of shares are held by institutions, a stable blue-chip base typical of a Dividend Aristocrat, providing deep liquidity and low share turnover.
Top holders — index giants: Largest holders include Vanguard and BlackRock as core index owners, alongside State Street, plus active value and income managers attracted by the dividend-growth record.
Dai-ichi Life strategic stake: Japan's Dai-ichi Life holds a long-standing strategic equity stake tied to Aflac Japan's distribution and alliance, aligning a key partner with shareholders.
Low insider ownership: Insider ownership is modest (low single-digit percent), centered on the Amos founding family legacy and management; governance is board-driven rather than founder-controlled.
High public float: Float is essentially the full share count outside index and strategic holders, supporting tight spreads and steady trading in a low-beta name.
Income-investor holder base: The shareholder register skews toward dividend-growth and total-return funds; the 44-year increase streak and buyback cadence are central to the holding thesis.

Recommendation

Summary

Rating

HOLD

Conviction

Medium

Price Target

$118

Timeframe

12 mo

Upside

+3%

Position Size

2%-4%

Entry Strategy

Tranche 1 — 35%

~$112

Initiate near the 50-DMA; the dividend-growth thesis is intact but shares sit near 52-week highs with limited upside to the ~$116 average target.

Tranche 2 — 35%

~$108

Add at the 200-DMA zone on any FX- or earnings-driven pullback, where the yield improves toward ~2.3%.

Tranche 3 — 30%

~$100

Reserve for a flush toward the $97-$100 52-week-low area — a higher-yield, higher-conviction entry for a long-term income hold.